Bextra injury Pennsylvania

Bextra® injury in Pennsylvania

If you are currently taking Bextra check with your doctor.

On April 7, 2005 the FDA announced that it has asked Pfizer, Inc. to withdraw Bextra from the market "because the overall risk versus benefit profile for the drug is unfavorable."

Bextra® is a non-steroidal anti-inflammatory drug (NSAIDs), known as a COX-2 selective agent. It's generic name is Valdecoxib and comes and 10 or 20 milligram doses. It is prescribed for inflammation and pain from arthritis or menstrual cramping. Other drugs in this class include Celebrex® and Vioxx®. Doctors switched patients from Vioxx® to Bextra® when Merck voluntarily removed it from the market due studies showing an increased risk for heart attack and stroke.

bextra site map

Attorney Information

FDA Information

For a free case evaluation from a Pennsylvania attorney, click here: lawforum

Click here to read the FDA questions and answers about strengthened warnings on Bextra® boxes.

Munley, Munley & Cartwright, P.C. is a Pennsylvania law office which has breaking news and information about this lawsuit

Autism Education Materials!

To report any unexpected adverse or serious events associated with the use of Bextra® contact the FDA MedWatch program on the internet or at 1-800-FDA-1088